Literature DB >> 15379616

Non-invasive treatment of critical limb ischemia.

Curt Diehm1, Nicolas Diehm.   

Abstract

Patients with threatening ischemia of the lower extremities constitute a steadily increasing patient population owing to the increasing age of the general population and the growing incidence of diabetes. The goals of treatment for patients with critical limb ischemia (CLI) are pain control, wound healing, limb salvage, improvement of quality of life and reduction of overall cardiovascular risk. A high proportion of patients with CLI have coexisting diseases, mainly cardiovascular and renal disorders. The purpose of this article is to summarize non-invasive treatment options in patients with CLI and to critically review the results of landmark investigations dealing with conservative therapy for chronic critical limb ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379616     DOI: 10.2174/1568006043336069

Source DB:  PubMed          Journal:  Curr Drug Targets Cardiovasc Haematol Disord        ISSN: 1568-0061


  2 in total

1.  A novel bFGF-GH injection therapy for two patients with severe ischemic limb pain.

Authors:  Naomi Ito; Shigeru Saito; Makiko Hardy Yamada; Shiro Koizuka; Hideaki Obata; Koichi Nishikawa; Yasuhiko Tabata
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

Review 2.  Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.

Authors:  Indrani Sen; Sunil Agarwal; Prathap Tharyan; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2018-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.